Credit Suisse Group Analysts Give Exxon Mobil (NYSE:XOM) a $74.00 Price Target

Share on StockTwits

Exxon Mobil (NYSE:XOM) has been given a $74.00 target price by stock analysts at Credit Suisse Group in a note issued to investors on Friday, Borsen Zeitung reports. The firm presently has a “neutral” rating on the oil and gas company’s stock. Credit Suisse Group’s price target would suggest a potential upside of 5.29% from the stock’s current price.

Several other equities analysts have also recently weighed in on XOM. Berenberg Bank reissued a “hold” rating and set a $76.00 price objective on shares of Exxon Mobil in a research report on Thursday, April 11th. Royal Bank of Canada cut Exxon Mobil from an “outperform” rating to a “sector perform” rating and cut their price objective for the stock from $100.00 to $90.00 in a research report on Thursday, July 18th. They noted that the move was a valuation call. HSBC reissued a “neutral” rating and set a $86.50 price objective on shares of Exxon Mobil in a research report on Thursday, May 23rd. Goldman Sachs Group reissued a “hold” rating and set a $80.00 price objective on shares of Exxon Mobil in a research report on Monday, April 29th. Finally, Tudor Pickering initiated coverage on Exxon Mobil in a research report on Monday, April 8th. They set a “hold” rating and a $82.49 price objective for the company. Four equities research analysts have rated the stock with a sell rating, fourteen have issued a hold rating and six have given a buy rating to the company. The company presently has an average rating of “Hold” and an average target price of $83.29.

Shares of NYSE XOM traded down $1.47 during trading hours on Friday, hitting $70.28. 18,940,521 shares of the company’s stock were exchanged, compared to its average volume of 11,540,170. Exxon Mobil has a 1-year low of $64.65 and a 1-year high of $87.36. The company has a debt-to-equity ratio of 0.10, a current ratio of 0.77 and a quick ratio of 0.50. The stock has a market cap of $303.58 billion, a PE ratio of 14.26, a price-to-earnings-growth ratio of 1.95 and a beta of 0.97. The firm has a 50-day moving average of $75.65.

Exxon Mobil (NYSE:XOM) last posted its quarterly earnings data on Friday, August 2nd. The oil and gas company reported $0.73 earnings per share for the quarter, topping the consensus estimate of $0.68 by $0.05. Exxon Mobil had a return on equity of 9.63% and a net margin of 6.49%. The business had revenue of $69.09 billion during the quarter, compared to analysts’ expectations of $64.47 billion. During the same quarter in the previous year, the firm earned $0.92 EPS. The firm’s revenue was down 6.0% compared to the same quarter last year. On average, research analysts predict that Exxon Mobil will post 3.33 earnings per share for the current year.

In other news, VP Bryan W. Milton sold 6,033 shares of the stock in a transaction that occurred on Wednesday, May 15th. The stock was sold at an average price of $76.34, for a total value of $460,559.22. Following the completion of the transaction, the vice president now directly owns 219,423 shares of the company’s stock, valued at approximately $16,750,751.82. The sale was disclosed in a legal filing with the SEC, which is available at this link. Corporate insiders own 0.05% of the company’s stock.

Several institutional investors and hedge funds have recently modified their holdings of the company. Sigma Investment Counselors Inc. boosted its position in Exxon Mobil by 0.4% in the 2nd quarter. Sigma Investment Counselors Inc. now owns 35,823 shares of the oil and gas company’s stock valued at $2,745,000 after buying an additional 142 shares during the last quarter. Riverstone Advisors LLC boosted its position in Exxon Mobil by 0.5% in the 2nd quarter. Riverstone Advisors LLC now owns 30,657 shares of the oil and gas company’s stock valued at $2,349,000 after buying an additional 142 shares during the last quarter. Alpha Windward LLC boosted its position in Exxon Mobil by 3.1% in the 2nd quarter. Alpha Windward LLC now owns 4,830 shares of the oil and gas company’s stock valued at $364,000 after buying an additional 144 shares during the last quarter. Saratoga Research & Investment Management boosted its position in Exxon Mobil by 4.1% in the 2nd quarter. Saratoga Research & Investment Management now owns 3,725 shares of the oil and gas company’s stock valued at $285,000 after buying an additional 145 shares during the last quarter. Finally, Jupiter Wealth Management LLC boosted its position in Exxon Mobil by 0.4% in the 2nd quarter. Jupiter Wealth Management LLC now owns 40,712 shares of the oil and gas company’s stock valued at $3,073,000 after buying an additional 145 shares during the last quarter. 54.52% of the stock is owned by institutional investors and hedge funds.

About Exxon Mobil

Exxon Mobil Corporation explores for and produces crude oil and natural gas in the United States, Canada/Other Americas, Europe, Africa, Asia, and Australia/Oceania. It operates through Upstream, Downstream, and Chemical segments. The company is also involved in the manufacture, trade, transport, and sale of crude oil, petroleum products, and other specialty products; and manufactures and markets petrochemicals, including olefins, polyolefins, aromatics, and various other petrochemicals.

Featured Story: Why Net Income is Important to Investors

Analyst Recommendations for Exxon Mobil (NYSE:XOM)

Receive News & Ratings for Exxon Mobil Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exxon Mobil and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

SpartanNash  Lifted to “Hold” at Pivotal Research
SpartanNash Lifted to “Hold” at Pivotal Research
SpartanNash  Lifted to “Hold” at ValuEngine
SpartanNash Lifted to “Hold” at ValuEngine
ValuEngine Lowers Sportsman’s Warehouse  to Sell
ValuEngine Lowers Sportsman’s Warehouse to Sell
Sorrento Therapeutics  Raised to “Hold” at Zacks Investment Research
Sorrento Therapeutics Raised to “Hold” at Zacks Investment Research
Sierra Oncology  Upgraded at Zacks Investment Research
Sierra Oncology Upgraded at Zacks Investment Research
Zacks Investment Research Lowers Sierra Oncology  to Hold
Zacks Investment Research Lowers Sierra Oncology to Hold


© 2006-2019 Ticker Report